Following our observations that TP53-dependent activation of NTRK1 is statistically significantly associated with favourable neuroblastoma patient survival [11], we hypothesised that an activated NTRK1-PTPN6-TP53 module could be an independent predictor of higher survival probability of neuroblastoma patients. Here, TP53 is linked to neuroblastoma.